Article
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Cancer - 15 Sept 2017
Ali Siraj M, Yao Ming, Yao Jicheng, Wang Jing, Cheng Yuwei, Schrock Alexa B, Chirn Gung-Wei, Chen Hui, Mu Shuo, Gay Laurie, Elvin Julia A, Suh James, Miller Vincent A, Stephens Philip J, Ross Jeffrey S, Wang Kai
Abstract excerpt
BACKGROUND: To date, no targeted therapy has been approved for nasopharyngeal carcinoma (NPC), and this underscores the need for an in-depth understanding of clinically relevant genomic alterations (CRGAs). METHODS: Comprehensive genomic profiling was performed for 190 NPC patients, including 20 patients with nasopharyngeal adenocarcinoma (NPAC), 62 patients with nasopharyngeal squamous cell carcinoma (NPSCC),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
